SUPN SUPERNUS PHARMACEUTICALS INC
2026Q1 · CUSIP 868459108 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
324
Δ holders QoQ
-7
Breadth percentile
Top 82%
Whale holders
158
Δ whales
+2
Inst. holding value
$3.0B
New positions
43
Closed positions
50
Price momentum (1Q)
-6.4%
Put / Call
4/3
Breadth history (34 quarters)
Past Lit Events & Aftermath 4 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2024Q3 | Top 11% | -6.2% | -9.1% |
| 2022Q4 | Top 18% | -9.5% | -19.9% |
| 2022Q3 | Top 6% | +16.5% | +4.7% |
| 2018Q1 | Top 17% | -23.0% | -23.8% |
Options Sentiment
Put holders
4
QoQ: 0
Call holders
3
QoQ: -2
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.51
EPS YoY
-145.9%
Revenue (TTM)
$0.8B
Revenue YoY
+16.3%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)